PEDIATRICS Vol. 106 No. 6 December 2000, pp. 1413-1421
Trends in Intussusception-Associated Hospitalizations and Deaths Among US Infants
Received Feb 9, 2000; accepted Apr 18, 2000.
,
,
,
From the * Viral Gastroenteritis Section, Division of Viral and
Rickettsial Diseases, Centers for Disease Control and Prevention, US
Department of Health and Human Services, Atlanta, Georgia;
Preventive Medicine Residency Program, Centers for Disease Control
and Prevention, Atlanta, Georgia; § Office of the Director, Division of
Viral and Rickettsial Diseases, Centers for Disease Control and
Prevention, Atlanta, Georgia;
Disease Investigations and
Surveillance Branch, Division of Communicable Disease Control,
California Department of Health Services, Berkeley, California;
¶ Epidemiology Resource Center, Indiana State Department of Health,
Indianapolis, Indiana; # Indian Health Service, US Department of Health
and Human Services, Rockville, Maryland; and the ** Division of Public
Health, Georgia Department of Human Resources, Atlanta, Georgia.
Context. The newly licensed tetravalent rhesus-human reassortant rotavirus vaccine has been withdrawn following reports of intussusception among vaccinated infants.
Objective. To describe the epidemiology of intussusception-associated hospitalizations and deaths among US infants.
Design. This retrospective cohort study examined hospital discharge data from the National Hospital Discharge Survey for 1988-1997, Indian Health Service (IHS) for 1980-1997, California for 1990-1997, Indiana for 1994-1998, Georgia for 1997-1998, and MarketScan for 1993-1996, and mortality data from the national multiple cause-of-death data for 1979-1997 and linked birth/infant death data for 1995-1997.
Patients. Infants (<1 year old) with an International Classification of Diseases, Ninth Revision, Clinical Modification code for intussusception (560.0) listed on their hospital discharge or mortality record, respectively.
Results. During 1994-1996, annual rates for intussusception-associated infant hospitalization varied among the data sets, being lowest for the IHS (18 per 100 000; 95% confidence interval [CI] = 9-35 per 100 000) and greatest for the National Hospital Discharge Survey (56 per 100 000; 95% CI = 33-79 per 100 000) data sets. Rates among IHS infants declined from 87 per 100 000 during 1980-1982 to 12 per 100 000 during 1995-1997 (relative risk =7.6, 95% CI = 3.2-18.2). Intussusception-associated hospitalizations were uncommon in the first 2 months of life, peaked from 5 to 7 months old, and showed no consistent seasonality. Intussusception-associated infant mortality rates declined from 6.4 per 1 000 000 live births during 1979-1981 to 2.3 per 1 000 000 live births during 1995-1997 (relative risk = 2.8, 95% CI = 1.8-4.3). Infants whose mothers were <20 years old, nonwhite, unmarried, and had an education level below grade 12 years were at an increased risk for intussusception-associated death.
Conclusions. Intussusception-associated hospitalization rates varied among the data sets and decreased substantially over time in the IHS data. Although intussusception-associated infant deaths in the United States have declined substantially over the past 2 decades, some deaths seem to be related to reduced access to, or delays in seeking, health care and are potentially preventable.intussusception, hospitalizations, deaths, risk factors, infants. .
This article has been cited by other articles:
![]() |
A. Kempe, M. M. Patel, M. F. Daley, L. A. Crane, B. Beaty, S. Stokley, J. Barrow, C. Babbel, L. M. Dickinson, J. L. Tempte, et al. Adoption of Rotavirus Vaccination by Pediatricians and Family Medicine Physicians in the United States Pediatrics, November 1, 2009; 124(5): e809 - e816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Tate, L. Simonsen, C. Viboud, C. Steiner, M. M. Patel, A. T. Curns, and U. D. Parashar Trends in Intussusception Hospitalizations Among US Infants, 1993-2004: Implications for Monitoring the Safety of the New Rotavirus Vaccination Program Pediatrics, May 1, 2008; 121(5): e1125 - e1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F Heyse, B. J Kuter, M. J Dallas, and P. Heaton for the RE Evaluating the safety of a rotavirus vaccine: the REST of the story Clinical Trials, April 1, 2008; 5(2): 131 - 139. [Abstract] [PDF] |
||||
![]() |
M. Buettcher, G. Baer, J. Bonhoeffer, U. B. Schaad, and U. Heininger Three-Year Surveillance of Intussusception in Children in Switzerland Pediatrics, September 1, 2007; 120(3): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kempe, M. F. Daley, U. D. Parashar, L. A. Crane, B. L. Beaty, S. Stokley, J. Barrow, C. Babbel, L. M. Dickinson, M.-A. Widdowson, et al. Will Pediatricians Adopt the New Rotavirus Vaccine? Pediatrics, January 1, 2007; 119(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Warfield, S. E. Blutt, S. E. Crawford, G. Kang, and M. E. Conner Rotavirus Infection Enhances Lipopolysaccharide-Induced Intussusception in a Mouse Model J. Virol., December 15, 2006; 80(24): 12377 - 12386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Tai, A. T. Curns, U. D. Parashar, J. S. Bresee, and R. I. Glass Rotavirus Vaccination and Intussusception: Can We Decrease Temporally Associated Background Cases of Intussusception by Restricting the Vaccination Schedule? Pediatrics, August 1, 2006; 118(2): e258 - e264. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vesikari, D. O. Matson, P. Dennehy, P. Van Damme, M. Santosham, Z. Rodriguez, M. J. Dallas, J. F. Heyse, M. G. Goveia, S. B. Black, et al. Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine N. Engl. J. Med., January 5, 2006; 354(1): 23 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y E Chen, S Beasley, K Grimwood, and and the New Zealand Rotavirus Study Group Intussusception and rotavirus associated hospitalisation in New Zealand Arch. Dis. Child., October 1, 2005; 90(10): 1077 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Applegate Clinically Suspected Intussusception in Children: Evidence-Based Review and Self-Assessment Module Am. J. Roentgenol., September 1, 2005; 185(3_supp): S175 - S183. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-T. T. Li, R. L. Davis, and N. S. Weiss Intussusception and Oral Poliovirus Vaccination: Is There an Association? Am. J. Epidemiol., September 15, 2004; 160(6): 576 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kolsen Fischer, K. Bihrmann, M. Perch, A. Koch, J. Wohlfahrt, M. Kare, and M. Melbye Intussusception in Early Childhood: A Cohort Study of 1.7 Million Children Pediatrics, September 1, 2004; 114(3): 782 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bajaj and M. G. Roback Postreduction Management of Intussusception in a Children's Hospital Emergency Department Pediatrics, December 1, 2003; 112(6): 1302 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. H. Chang, P. F. Smith, J. Ackelsberg, D. L. Morse, and R. I. Glass Intussusception, Rotavirus Diarrhea, and Rotavirus Vaccine Use Among Children in New York State Pediatrics, July 1, 2001; 108(1): 54 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Murphy, P. M. Gargiullo, M. S. Massoudi, D. B. Nelson, A. O. Jumaan, C. A. Okoro, L. R. Zanardi, S. Setia, E. Fair, C. W. LeBaron, et al. Intussusception among Infants Given an Oral Rotavirus Vaccine N. Engl. J. Med., February 22, 2001; 344(8): 564 - 572. [Abstract] [Full Text] [PDF] |
||||











